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Abstract
IgE antigen complexes induce increased specific T cell proliferation and increased specific IgG production. Immediately after
immunization, CD23+ B cells capture IgE antigen complexes, transport them to the spleen where, via unknown mechanisms,
dendritic cells capture the antigen and present it to T cells. CD23, the low affinity IgE receptor, binds IgE antigen complexes
and internalizes them. In this study, we show that these complexes are processed onto B-cell derived exosomes
(bexosomes) in a CD23 dependent manner. The bexosomes carry CD23, IgE and MHC II and stimulate antigen specific T-cell
proliferation in vitro. When IgE antigen complex stimulated bexosomes are incubated with dendritic cells, dendritic cells
induce specific T-cell proliferation in vivo, similar to IgE antigen complexes. This suggests that bexosomes can provide the
essential transfer mechanism for IgE antigen complexes from B cells to dendritic cells.
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Introduction
Antibody, in complex with its antigen, provides the immune
system with a feedback response against the complexed antigen.
This feedback mechanism results in immune stimulation or
suppression depending upon the antibody class (reviewed in [1]).
IgE, complexed with antigen, has long been shown to induce a
significantly increased immune response over antigen alone. This
response results in increased antigen specific T cell proliferation
and antigen specific IgG in vivo [2]. The low affinity receptor for
IgE (CD23) is traditionally known for its role in the negative
regulation of IgE synthesis. But, CD23 has additionally been
known to internalize IgE antigen complexes and promote antigen
presentation. Extensive studies using CD232/2 animals proved
CD23 to be essential to the immunostimulatory properties of IgE
antigen complexes [2]. Combining antigen presentation properties
of CD23 with the observed immunostimulation led to the
hypothesis that antigen presentation by CD23+ B cells was
responsible for these activities. This hypothesis was challenged by
the recent finding that B cells rapidly transfer the antigen to the
spleen [3] and were dispensable after 4 hours post IgE antigen
complex injection. After that period, dendritic cells (DCs) were
required [4]. These intriguing findings suggested that IgE antigen
complexes or fragments thereof were being carried to the
secondary lymphoid system, in this case the spleen, by CD23+ B
cells and then were being transferred to DCs. This led to the
obvious question, what is the mechanism of this transfer?
Henningson et al [4] suggested two possibilities; trogocytosis by
DCs or exosomal mediated transfer from B cells to DCs.
Exosomes are defined as tiny membrane bound particles
ranging from 30–150 nm. Although originally discovered in the
1980 s and thought to be primarily for cellular waste [5], exosomal
research has undergone a resurgence given the protein and micro-
RNA cargo that is packed into these particles (reviewed in [6]). In
a previous publication, we demonstrated that CD23 and its
protease, ADAM10 were found in B cell derived exosomes
(bexosomes) from both mouse and human B cells [7]. Additionally,
b2-adrenergic stimulation of B cells further increased both CD23
and ADAM10 levels in bexosomes [8]. In this study we show that
B cells stimulated with anti-CD40 and IL-4, in the presence of IgE
antigen complexes, release bexosomes that contain both CD23
and IgE. In agreement with earlier studies [9], these bexosomes
were capable of directly stimulating antigen specific T cells
in vitro, presumably via the MHC peptide complexes found on
these bexosomes. Intriguingly, this stimulation was greatly
enhanced if the bexosomes were isolated from B cells stimulated
in the presence of IgE antigen complexes, and this enhanced
stimulation was CD23 dependent. This data supports earlier
in vitro studies where B cells were shown to directly present IgE
antigen complexes, taken up via CD23, to T cells [10]. Yet,
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in vivo, direct injection of bexosomes did not cause increased T
cell proliferation, which agrees with the requirement of DCs [4].
In contrast, culture of bexosomes with bone marrow derived DCs
(BMDC), followed by isolation and injection of DCs did directly
enhance in vivo antigen specific T cell proliferation. Overall, this
supports the hypothesis that bexosomes are responsible for antigen
transfer from B cells to DCs, thus, providing a mechanism and
suggesting a model to explain the importance of DCs in the
immunostimulatory activity of IgE complexes.
Materials and Methods
Mice
Mice were maintained in the Virginia Commonwealth Univer-
sity animal facility in accordance to guidelines for the humane
treatment of laboratory animals set forth by the National Institutes
of Health and the American Association for the Accreditation of
Laboratory Animal Care. C57BL/6 and BALB/C mice were
purchased from Jackson Labs; DO11.10 and OTII mice were
progeny from breeding pairs purchased from Jackson Laboratory.
CD23 knockout (BALB/C) [11] or B cell specific ADAM10
deficient mice (ADAM10B2/2)(BALB/C backcross at least 6
generations) [12] were bred in house. Mice were euthanized with
isoflurane inhalation, followed by cervical dislocation. All mouse
protocols were approved by the Virginia Commonwealth Univer-
sity Institutional Animal Care and Use Committee, approval
numbers are AM10065 and AM10269.
Exosomal Cell Cultures
All fetal bovine serum (FBS) used in exosome cultures was first
centrifuged at 100,000xg for 2 hours to deplete bovine exosomes.
Splenic B cells were isolated using B220 positive magnetic bead
selection as per manufacturer protocol (Miltenyi Macs system) and
cultured for 3 days in 6 well plates at 16106 cells/mL in cRPMI
1640 [13] containing 1 mg/mL anti-CD40 (HM40-3) (Biolegend)
and 10,000 U/mL IL-4 (gift from Bill Paul NIH). When indicated,
10 mg/ml of anti-TNP- IgE (IGELb4) [14] was present. When
larger amounts of exosomes were needed, B lymphoma line
M12.4.5 (M12) [15] was used. M12 cells (16106cells/mL – total
cell number 3–56108) were cultured for 24 hrs in cRPMI 1640/
10% FBS (exosome-free as described previously) containing anti-
CD40, IL-4, and anti-TNP (IGELb4) or anti-DNP IgE (10 mg/
mL) [14,16].
Exosomal Isolation
Exosomes were isolated as previously described [17]. Briefly,
apoptotic bodies in cell free supernatants were removed by
centrifugation at 27,0006g for 20 minutes. Finally, exosomes were
harvested by spinning at 100,0006g for 1 hour; the exosome pellet
was resuspended in 5 mL of HBS plus 2mM Ca2+ and pelleted
again at 100,0006g for 1 hour. Final exosome pellet were
resuspended in HBS plus 2mM Ca2+ and then passed through a
0.2 mm filter to remove particles larger than 200 nm and to assure
sterility. Bradford Assay exosome yields were approximately 1.0–
1.62 mg/mL, from B cell cultures and about 10-fold higher with
M12 cultures depending upon original cell number.
Western Blotting
Western Blots were performed using 10% Bis-Tris gels and a
mini gel system (Life Technologies). Equal amounts of exosome
protein (20 mg) were loaded. NuPage MES SDS Running Buffer
and NuPAGE MES Transfer Buffer were used according to
manufacturer’s instructions. After electrophoresis and transfer to
nitrocellulose paper, blocking was performed using 5% powdered
milk solution/0.05% v/v Tween-20 (two hours) followed by the
primary antibody incubation (1 hour minimum) followed by HRP
secondary antibody. Antibodies used were as follows: Mouse anti-
mouse MHCII H2-I/Adb (5K43) (Santa Cruz); Rabbit anti-
mouse IgE (Fc specific) (Acris); goat anti-rabbit HRP (Southern
Biotech); Rabbit anti-mouse CD23 as described [18]; Rabbit anti-
CD9 (polyclonal) (Sigma).
Specific T cell proliferation
In vitro. DO11.10 T cells were isolated using magnetic bead
selection (Miltenyi Macs)B220+, CD11b+ and CD11c+ cells were
depleted and then CD4 positive T cells were isolated using L3T4,
non-activating selection. Bexosomes (15–20 mg/100 mL) were
added to 16105 DO11.10 T cells in a final volume of 200 mL
cRPMI/well in 96 well plates; TNP or DNP-OVA was added in
Figure 1. IgE and CD23 are associated with bexosomes. (A)
Bexosomes were isolated from B cell cultures stimulated with anti-
CD406 IL-4 or IgE as indicated. 1.2511 fold increase60.177SD between
lanes three and four. Equal bexosome protein was loaded on each lane
and the blot was probed with polyclonal anti-CD23. Blot was probed
with anti-MHC class II or anti-CD9and the result is shown at the bottom
of (A). (B) Exosomes from B cell cultures stimulated with anti-CD40 and
IgE (All lanes). IL-4 stimulation is as indicated. Lanes 1 and 2 are
bexosomes from WT mice, Lanes, 3 and 4 are bexosomes from CD232/2
mice. Blots are representative of at least three independent experi-
ments. (C) Graph represents fold difference in densitometry between
anti-CD23 blots for anti-CD40/IL4 and anti-CD40/IL4/IgE.
doi:10.1371/journal.pone.0110609.g001
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indicated amounts. After 96 hours, cells were pulsed with 1 mCi/
well of [H3]-thymidine for 24 hours (Perkin Elmer). Plates were
then harvested using a Filtermate cell harvester onto GFC plates.
Assays were read using a Topcount Plate Counter (Perkin Elmer,
Waltham, MA).
In vivo. (B cell specific ADAM10 deficient) ADAM10B2/
2BALB/C or WT BALB/C mice were injected with IgE immune
complexes (20 mg TNP-OVA +50 mg anti-TNP-IgE [4]. For
bexosome or BMDC derived dexosome experiments, bexosomes
were added to the DC cultures for 24 hours. After washing, LPS
was added and cultures were continued for 72 hours and
dexosomes were then isolated by centrifugation. Dexosomes,
BMDCs or bexosomes or were i.v. injected into BALB/C mice
that had been adoptively transferred (AT) with DO11.10 total
splenocytes 24 hours previous. After 3 days, DO11.10 cell
numbers in the spleen were determined either by flow cytometry
or immunohistochemistry as described [4].
Flow Cytometry/Immunohistochemistry
Single cell suspensions were labeled with antibodies for
cytometric analysis. Antibodies included unlabeled anti-mouse
FccR (2.4G2), FITC-conjugated anti-mouse D011.10 (KJ1-26)
(Biolegend), and PE-conjugated anti-mouse CD4 (145-2C11)
(Biolegend). Flow cytometric analysis was performed using the
Canto (BD Biosciences). Data analysis was conducted using
FlowJo software v7.6.5 (Tree Star). Sections were prepared from
frozen tissue and fixed with cold Acetone. Sections were blocked
using 5% normal horse serum plus 1.5% BSA. Sections were
stained using Biotinylated anti-DO11.10 (KJ1-26) followed by
Figure 2. Bexosome-induced antigen specific T cell proliferation is enhanced by IgE, only in the presence of CD23and in vivo IgE
immune complex T proliferation is enhanced in ADAM10B2/2mice. (A) B cell cultures were stimulated as in Methods. Stimulated B cells from
either WT or CD232/2 mice were pre-incubated 6IgE for 24 hours and then IgE/Ag ICs were added for an additional 24 hours. Bexosomes were
isolated and cultured with purified Ag-specific DO11 T cells for 3 days. Proliferation was determined using a [3H]-thymidine pulse (Methods). (B,C) On
day 21 WT or ADAM10B2/2 mice were adoptively transferred with Ag-specific DO11 T cells and on day 0 immunized with IgE/Ag ICs (Methods); on
day 3, spleens were removed and examined for expanded Ag specific DO11+ CD4+ T cells by flow cytometry (B) or immunohistochemistry (C). *p.
0.05, ***p.0.0005; n = at least five per group.
doi:10.1371/journal.pone.0110609.g002
Figure 3. Increased in vivo T proliferation with i.v. injected DCs
incubated with bexosomes. In vitro differentiated LPS activated DCs
were incubated with bexosomes stimulated with IgE/Ag ICs plus
10 mgOVA, 10 mgOVA or 300 mg OVA for three days. DCs were
harvested and equivalent cells were injected into mice AT with DO11
cells. Spleens were assessed by flow cytometry on Day 3. Percent
DO11TgTCR+ cells out of total CD4+ T cells were plotted. *p.0.05; n = 5
per group.
doi:10.1371/journal.pone.0110609.g003
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Streptavidin-APC and anti-B220-PE (RA3-6B2) (Biolegend).
Slides were cover slipped utilizing Vectashield Hardset (Vector
Labs) and imaged on the Leica TCS-SP2 AOBS CLSM Confocal
laser-scanning microscope.
BMDC culture
Mouse bone marrow-derived dendritic cells (BMDC’s) were
derived from femurs of WT mice and cultured in complete RPMI
(cRPMI) 1640 containing 10% FBS, 2mM L-glutamine, 100 U/
mL penicillin, 100 mg/mL streptomycin, 1mM HEPES (Quality
Biological, Inc.), and 1mM sodium pyruvate (Cellgro). Cultures
were supplemented with IL-4 1 ng/mL (Peprotech) and GM-CSF
50 ng/mL (Peprotech). Mature BMDC were harvested after
6 days of culture [9].
Statistical Analysis
When dealing with two groups, p-values were calculated using
unpaired two-tailed Student’s t-tests in GraphPad Prism. Error
bars represent the standard deviation (SD) between samples. p,
0.05 is considered significant.
Results and Discussion
IgE is associated with bexosomes in a CD23 dependent
manner
As mentioned, CD23 and ADAM10 are both found associated
with bexosomes [7]. In order to determine if IgE is additionally
associated, B cells were stimulated with anti-CD406 IL-4 in the
presence of IgE/Ag ICs. After 48 hours of culture, bexosomes
were isolated by centrifugation. Equal amounts of protein were
analyzed by Western blotting. Fig. 1A,C shows that IL-4
stimulated B cells increases bexosomal CD23 levels and that IgE
addition increases CD23. The blot indicated equal MHC class II
expression. Interestingly, MHC class II levels were not increased
by IL-4, in contrast to the well-known cell surface increase induced
by this cytokine. The bexosomes were additionally blotted for the
tetraspanin CD9, which is an exosomal marker (Fig. 1A). In an
earlier study using LPS as the activator [7], we found that
ADAM10 was needed for bexosomal CD23 expression. With anti-
CD40, CD23 is present even if ADAM102/2 B cells are used;
although the CD23 expression level is lower (data not shown). This
indicates that CD40 activation is more efficient in allowing CD23
incorporation into bexosomes. In Fig. 1B, the blot is examined
using an e-specific anti-IgE antibody, and lane 1 shows a strong
Figure 4. Model for the mechanism of IgE immune complex mediated humoral immunity enhancement. IgE immune complexes are
picked up by CD23+ B cells and this allows efficient transfer into the spleen. Once there, bexosomes are released and picked up by DCs which then
activate antigen specific T cells and subsequently give the enhanced humoral response that is seen in IgE antigen complex injected animals.
doi:10.1371/journal.pone.0110609.g004
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85Kd band indicates the presence of IgE. The amount of IgE was
additionally increased in the presence of IL-4 (lane 2). This band
was not present when B cells lacking CD23 were used (lanes 3 and
4) regardless of IL-4 stimulation. Thus, CD40-mediated CD23+ B
cell activation results in release of bexosomes that contains CD23
and bound IgE.
Increased in vivo antigen specific T cell proliferation is
seen with bexosomes from anti-CD40/IL4 activated B
cells when IgE/antigen complexes are present in the
culture
As mentioned above, bexosomes are known to induce antigen
specific T cell proliferation if isolated from B cells cultured in the
presence of the specific antigen [9]. The finding (Fig. 1) that CD23
and IgE are present in bexosomes suggests that MHC class II
peptide loading should be enhanced when IgE complexes are
included in the culture. That this is indeed true is shown in Fig. 2A
where the initial B cells were cultured with increasing amounts of
antigen (TNP-OVA) alone or the same plus anti -TNP-IgE. With
B cells from either BALB/C or C57BL/6 mice and the
corresponding strains of OVA-specific T cells, DO11.10 (Fig. 2A)
or OTII (Fig. S1), increased specific T cell proliferation is seen
when antigen specific IgE is present in the cultures. This data looks
quite similar to the studies that initially demonstrated the
enhanced antigen-presentation by IgE complexes with CD23+ B
cells [10] and relates to enhanced MHC class II loading due to the
increased antigen found in the endosomal compartments. Confir-
mation that both IgE and CD23 are necessary for the bexosomal
induced T cell proliferation is shown in Fig. 2A where increased T
proliferation is only seen when both are present. To determine
whether ADAM10 was also needed for the enhancement of
presentation, we turned to in vivo studies. WT or B cell-specific
ADAM10 deficient (ADAM10B2/2) BALB/C mice were i.v.
injected on day21 with 30 million DO11.10 total splenocytes. On
day 0, they were i.v. injected with anti-TNP IgE/TNP-OVA
complexes (Methods). Three days later, OVA-specific T-cell
proliferation was determined by flow cytometry and immunohis-
tochemistry. WT mice injected with IgE/Antigen complexes had
increased DO11.10 proliferation, as indicated by the number of
antigen specific T cells in the spleen, as compared to WT OVA
injected (Fig. 2B). This was as expected. But, the ADAM10B2/2
mice had significantly more DO11.10 proliferation than did the
WT. This finding was further confirmed by immunohistochem-
istry, where proliferation differences generally look more pro-
nounced. The enhanced OVA-specific DO11.10 cell number in
the T cell region of the spleen of the ADAM10B2/2 was clearly
evident (Fig. 2C). Thus, B cell ADAM10 is clearly not necessary
for IgE antigen complex stimulation since this enhancement is
seen. As the ADAM10B2/2 mice have been shown to have
enhanced CD23 expression [19], we hypothesize that the
increased CD23 leads to still further IgE-antigen incorporation
with enhanced MHC class II loading in the endosomal
compartment, leading to the results shown in Fig. 2B and C.
These studies also indicate that marginal zone B cells are not
necessary for IgE-antigen complex immunostimulation, since
marginal zone B cells are absent in ADAM10B2/2 mice [19]. It
also agrees with the observation that IgE complexes were found
bound to mainly follicular B cells and not to MZ B cells [4].
Bexosomes must first go through DCs in order to
stimulate T cells in vivo
To directly test if bexosomes from B cells activated with anti-
CD40 and IL-4 would stimulate T cells in vivo, bexosomes were
isolated from B cells activated as in Fig. 2A with IgE/OVA
complexes. They were injected into BALB/C mice AT with OVA-
specific DO11.10 cells. This was ineffectual, so to increase the level
of bexosomes for injection, 36108 M12.4.5 cells were activated
instead of primary B cells. Bexosomes were isolated and injected
into the OVA-specific T cell AT mice. In neither situation did we
observe increased levels of OVA-specific T cell proliferation when
the spleen was examined 3 days post bexosome injection (data not
shown). We considered that the most likely reason for this failure
was that the bexosomes were not efficiently crossing the HEV to
enter the peri-arteriolar lymphoid sheath (PALs) tissue. To
increase chance for HEV crossing, bexosomes were cultured with
LPS activated BMDCs, and DC were isolated 3 days post culture
with bexosomes. In contrast to directly injected bexosomes,
passage of the bexosomes through DCs, with injection of the
DCs did cause a small but significant increase in OVA-specific
proliferation, as determined by flow cytometry (Fig. 3). This
increase was significantly higher than what was seen by control
DCs isolated from LPS activated cultured with the same amount
of TNP-OVA alone or increased amounts. While the increase in T
cell proliferation was not as dramatic as seen when directly
injecting IgE immune complexes (Fig. 2B,C), the results are clearly
compatible with exosomes being responsible for the transfer of
antigen to DCs as described by Henningsson et al [4]. Thus, we
propose the following model (Fig. 4): IgE immune complexes are
picked up by CD23+ B cells and this allows efficient transfer into
the spleen. Once there, bexosomes are released and picked up by
DCs which then activate antigen specific T cells and subsequently
give the enhanced humoral response that is seen in IgE antigen
complex injected animals [10]. Future studies could examine the
mechanism of CD23+ bexosomal release and ways to increase
transfer of the bexosome incorporated MHC class II cargo to DCs.
If successful, this would allow immunization strategies that take
advantage of the IgE immune complex stimulation that would
bypass any difficulties seen by FceRI interaction with IgE and
antigen, and still allow efficient sensitization with low amounts of
antigen.
Supporting Information
Figure S1 Bexosome-induced antigen specific T cell
proliferation is enhanced by IgE in C57BL/6 model of
OVA-specific T cell proliferation. B cell cultures stimulated
as in Methods. B cells were incubated with IgE for 24 hours and
then IgE/Ag ICs were added. Bexosomes were isolated. B cells
were from WT C57BL/6 mice. Bexosomes and purified Ag-
specific OTII T cells were cultured for 3 days and proliferation
determined using a [3H]-thymidine pulse (Methods).
(DOCX)
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